These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33484095)

  • 21. Management of non-progressive dysarthria: practice patterns of speech and language therapists in the Republic of Ireland.
    Conway A; Walshe M
    Int J Lang Commun Disord; 2015; 50(3):374-88. PubMed ID: 25652223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive-linguistic deficit and speech intelligibility in chronic progressive multiple sclerosis.
    Mackenzie C; Green J
    Int J Lang Commun Disord; 2009; 44(4):401-20. PubMed ID: 19294553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of clear speech intervention program on speech intelligibility in persons with idiopathic Parkinson's disease: A pilot study.
    Shin H; Shivabasappa P; Koul R
    Int J Speech Lang Pathol; 2022 Feb; 24(1):33-41. PubMed ID: 34229555
    [No Abstract]   [Full Text] [Related]  

  • 24. A pilot study into the effect of vocal exercises and singing on dysarthric speech.
    Tamplin J
    NeuroRehabilitation; 2008; 23(3):207-16. PubMed ID: 18560137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intelligibility as a clinical outcome measure following intervention with children with phonologically based speech-sound disorders.
    Lousada M; Jesus LM; Hall A; Joffe V
    Int J Lang Commun Disord; 2014; 49(5):584-601. PubMed ID: 24861159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of rate control on the intelligibility and naturalness of dysarthric speech.
    Yorkston KM; Hammen VL; Beukelman DR; Traynor CD
    J Speech Hear Disord; 1990 Aug; 55(3):550-60. PubMed ID: 2381196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-speech oro-motor exercises in post-stroke dysarthria intervention: a randomized feasibility trial.
    Mackenzie C; Muir M; Allen C; Jensen A
    Int J Lang Commun Disord; 2014; 49(5):602-17. PubMed ID: 24889103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Be Clear: A New Intensive Speech Treatment for Adults With Nonprogressive Dysarthria.
    Park S; Theodoros D; Finch E; Cardell E
    Am J Speech Lang Pathol; 2016 Feb; 25(1):97-110. PubMed ID: 26882004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intensive treatment of dysarthria in two adults with Down syndrome.
    Mahler LA; Jones HN
    Dev Neurorehabil; 2012; 15(1):44-53. PubMed ID: 22256834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation and cross-linguistic adaptation of the Frenchay Dysarthria Assessment (FDA-2) speech intelligibility tests: Hebrew version.
    Icht M; Bergerzon-Bitton O; Ben-David BM
    Int J Lang Commun Disord; 2022 Sep; 57(5):1023-1049. PubMed ID: 35714104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intelligibility, Articulation Rate, Fluency, and Communicative Efficiency in Typically Developing Children.
    Schölderle T; Haas E; Baumeister S; Ziegler W
    J Speech Lang Hear Res; 2021 Jul; 64(7):2575-2585. PubMed ID: 34232737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Speech characteristics in the congenital and childhood-onset forms of myotonic dystrophy type 1.
    Sjögreen L; Mårtensson Å; Ekström AB
    Int J Lang Commun Disord; 2018 May; 53(3):576-583. PubMed ID: 29327796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variability in the perceptual and physiological features of dysarthria following severe closed head injury: an examination of five cases.
    Theodoros DG; Murdoch BE; Stokes PD
    Brain Inj; 1995 Oct; 9(7):671-96. PubMed ID: 8680396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting Intelligibility Gains in Dysarthria Through Automated Speech Feature Analysis.
    Fletcher AR; Wisler AA; McAuliffe MJ; Lansford KL; Liss JM
    J Speech Lang Hear Res; 2017 Nov; 60(11):3058-3068. PubMed ID: 29075755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perceptual and Acoustic Effects of Dual-Focus Speech Treatment in Children With Dysarthria.
    Levy ES; Chang YM; Hwang K; McAuliffe MJ
    J Speech Lang Hear Res; 2021 Jun; 64(6S):2301-2316. PubMed ID: 33656916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Towards an automatic evaluation of the dysarthria level of patients with Parkinson's disease.
    Vásquez-Correa JC; Orozco-Arroyave JR; Bocklet T; Nöth E
    J Commun Disord; 2018; 76():21-36. PubMed ID: 30149241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Comparative Study of Auditory-Perceptual Speech Measures for the Early Detection of Mild Speech Impairments.
    Kuruvilla-Dugdale M; Threlkeld K; Salazar M; Nolan G; Heidrick L
    Semin Speech Lang; 2019 Nov; 40(5):394-406. PubMed ID: 31426103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of speech task on intelligibility in dysarthria: a case study of Parkinson's disease.
    Kempler D; Van Lancker D
    Brain Lang; 2002 Mar; 80(3):449-64. PubMed ID: 11896652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Speech Treatment Effects on Narrative Intelligibility in French-Speaking Children With Dysarthria.
    Moya-Galé G; Keller B; Escorial S; Levy ES
    J Speech Lang Hear Res; 2021 Jun; 64(6S):2154-2168. PubMed ID: 33719503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of rate control on speech rate and intelligibility of dysarthric speech.
    Van Nuffelen G; De Bodt M; Wuyts F; Van de Heyning P
    Folia Phoniatr Logop; 2009; 61(2):69-75. PubMed ID: 19287175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.